 |
David Sabatini Named One of the World’s Top
Young Innovators by Technology Review,
MIT’s Magazine of Innovation
CAMBRIDGE, Mass. (March 16, 2002) — The Whitehead Institute for Biomedical Research today announced that David Sabatini has been chosen as one of the world’s 100 Top Young Innovators by Technology Review, MIT’s Magazine of Innovation. The TR100, chosen by Technology Review, MIT’s award-winning magazine of innovation, consists of 100 young individuals whose innovative work in business and technology has a profound impact on today’s world. Nominees are recognized for their contribution in transforming the nature of technology in industries such as biotechnology, computing, energy, medicine, manufacturing, nanotechnology, telecommunications and transportation.
Sabatini and his colleagues have developed a new type of microarray technology that allows researchers to identify the function of thousands of proteins in parallel, within the context of their normal environment inside living cells. Such tools are crucial for scientists to mine the mammoth databank of the human genome and to realize its promise—discovery of disease genes, identification of new drugs, and development of therapies custom-tailored to fit patients' genetic profiles. Sabatini envisions eventually having the entire set of human proteins available on a handful of slides.
Sabatini will be honored on May 23 during a conference and awards ceremony at the Massachusetts Institute of Technology. The event, themed "The Innovation Economy: How Technology is Transforming Existing Businesses and Creating New Ones," includes a full day of conference sessions and panel discussions followed by an evening awards ceremony. Hosted by Technology Review’s Editor-in-Chief John Benditt and CNBC’s Consuelo Mack, conference speakers include international leaders such as Kenneth Starr Esq.; Clayton Christensen, Harvard Business School professor and author of The Innovators Dilemma; Nadine Strossen, president of the ACLU; Rodney Brooks, Director of the Artificial Intelligence Laboratory and Co-director of Project Oxygen, MIT; Richard Rashid, Senior Vice President, Microsoft Research; and David Tennenhouse, Vice President and Corporate Technology Group Director, Intel Corporation.
TR100’s unparalleled panel of judges includes:
- Dr. David Baltimore, President, California Institute of Technolog
- Alfred Berkeley III, Vice Chairman, NASDAQ
- Richard Demillo, Vice President and Chief Technology Officer, Hewlett-Packard
- Dr. Philippe Janson, Vice President, IBM Academy of Technology
- Dr. Robert M. Metcalfe, Venture Partner, Polaris Venture Partners
- Dr. Cherry A. Murray, Senior Vice President of Physical Science Research, Bell Labs/Lucent Technologies
- Nicholas Negroponte, Director, MIT Media Laboratory
- Dr. Judith Rodin, President, University of Pennsylvania
The Whitehead Institute for Biomedical Research is a non-profit, independent basic research and teaching institution. Whitehead is academically affiliated with the Massachusetts Institute of Technology but wholly responsible for its own research programs, governance, and finance.
About Technology Review Inc.
Technology Review, MIT’s magazine of Innovation, is the world's oldest technology magazine. The magazine, as well as its signature events and Internet businesses, delivers essential information on emerging technologies on the verge of commercialization. Since 1998, Technology Review’s paid circulation has more than tripled, from 92,000 to 310,000 (as of January 2002). Several hundred thousand current MIT alumni, faculty and students, senior technology thinkers and influencers—venture capitalists, chief scientists, researchers, senior corporate executives, investors, and innovators throughout the world—constitute the Technology Review community.
For more information on the Sabatini lab, please see the web feature Building a New Paradigm in Drug Discovery.
|
|
